This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CNO Financial Ratings Revised by S&P & Fitch, Outlook Stable
by Zacks Equity Research
CNO Financial (CNO) gets rated by S&P and Fitch, reflecting its reduced risk profile, balance sheet strength and operating measures.
Zacks.com featured highlights include: Hibbett Sports, Universal Forest, Citizens Financial, Westlake and Metlife
by Zacks Equity Research
Zacks.com featured highlights include: Hibbett Sports, Universal Forest, Citizens Financial, Westlake and Metlife
Pick These 7 Low Price-to-Sales Stocks for Optimum Returns
by Zacks Equity Research
A stock with a lower price-to-sales ratio is a more suitable investment than a stock with a high price-to-sales ratio.
MetLife Looks to Utilize Blockchain
by Mitchell Moore
MetLife(MET), the largest player in a $2.7 trillion life insurance industry, recently announced a trial run of a completely revamped claims process. Blockchain, the technology underpinning cryptocurrency, will be utilized by MetLife in this significant procedural change.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Why Adding MetLife (MET) to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on a strong revenue base and solid business realignment measures, MetLife (MET) holds great potential to reap benefits for investors.
Is MetLife (MET) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Income Stocks to Buy for June 14th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, June 14th
MGIC Investment's (MTG) May Insurance in Force Impressive
by Zacks Equity Research
MGIC Investment's (MTG) insurance in force was $213.3 billion, up 7% year over year.
MET or AIG: Which Multi-Line Insurer Looks More Attractive?
by Zacks Equity Research
Here we take a look at whether MET or AIG is better poised in the multi-line insurance industry, which is benefiting from rate increase, business diversification and product innovation.
Should Value Investors Consider MetLife (MET) Stock Now?
by Zacks Equity Research
Let's see if MetLife, Inc. (MET) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Why MetLife (MET) Could Be a Top Value Stock Pick
by Zacks Equity Research
MetLife (MET) seems to be a good value pick, as it has impressive value metrics, and is seeing solid earnings estimate revisions as well.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Down 0.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
MetLife (MET) Q1 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Metlife (MET) earnings gain from an increase in revenues, partly offset by rise in expenses.
MetLife (MET) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
MetLife (MET) delivered earnings and revenue surprises of 13.85% and -0.33%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Why MetLife (MET) is a Great Dividend Stock Right Now
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
The Zacks Analyst Blog Highlights: Visa, Boeing, Coca-Cola, MetLife and O'Reilly
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Visa, Boeing, Coca-Cola, MetLife and O'Reilly
MetLife (MET) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Revenue growth, cost-savings efforts to aid MetLife's (MET) earnings in Q1, which will be partly offset by lower investment income.
Top Research Reports for Visa, Boeing & Coca-Cola
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Visa (V), Boeing (BA) and Coca-Cola (KO).
Earnings Preview: MetLife (MET) Q1 Earnings Expected to Decline
by Zacks Equity Research
MetLife (MET) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a High-Growth Dividend Stock? MetLife (MET) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does MetLife (MET) have what it takes? Let's find out.
Will MetLife (MET) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
MetLife (MET) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.